231 related articles for article (PubMed ID: 28895473)
1. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation.
D'Ambrosi N; Cozzolino M; Carrì MT
Antioxid Redox Signal; 2018 Jul; 29(1):15-36. PubMed ID: 28895473
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model.
Dahlke C; Saberi D; Ott B; Brand-Saberi B; Schmitt-John T; Theiss C
J Neuroinflammation; 2015 Nov; 12():215. PubMed ID: 26597538
[TBL] [Abstract][Full Text] [Related]
3. Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS).
Niebrój-Dobosz I; Dziewulska D; Kwieciński H
Folia Neuropathol; 2004; 42(3):151-6. PubMed ID: 15535033
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
[TBL] [Abstract][Full Text] [Related]
5. Looking to the Future of the Role of Macrophages and Extracellular Vesicles in Neuroinflammation in ALS.
Carata E; Muci M; Di Giulio S; Mariano S; Panzarini E
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511010
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
7. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Hensley K; Mhatre M; Mou S; Pye QN; Stewart C; West M; Williamson KS
Antioxid Redox Signal; 2006; 8(11-12):2075-87. PubMed ID: 17034351
[TBL] [Abstract][Full Text] [Related]
8. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.
Philips T; Robberecht W
Lancet Neurol; 2011 Mar; 10(3):253-63. PubMed ID: 21349440
[TBL] [Abstract][Full Text] [Related]
10. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives.
Cieślak M; Roszek K; Wujak M
Purinergic Signal; 2019 Mar; 15(1):1-15. PubMed ID: 30430356
[TBL] [Abstract][Full Text] [Related]
11. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?
Cipollina G; Davari Serej A; Di Nolfi G; Gazzano A; Marsala A; Spatafora MG; Peviani M
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113845
[TBL] [Abstract][Full Text] [Related]
13. DREAM-Dependent Activation of Astrocytes in Amyotrophic Lateral Sclerosis.
Larrodé P; Calvo AC; Moreno-Martínez L; de la Torre M; Moreno-García L; Molina N; Castiella T; Iñiguez C; Pascual LF; Mena FJM; Zaragoza P; Y Cajal SR; Osta R
Mol Neurobiol; 2018 Jan; 55(1):1-12. PubMed ID: 28840473
[TBL] [Abstract][Full Text] [Related]
14. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
Apolloni S; Fabbrizio P; Parisi C; Amadio S; Volonté C
Mol Neurobiol; 2016 Jan; 53(1):518-531. PubMed ID: 25482048
[TBL] [Abstract][Full Text] [Related]
15. Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis.
Shijo T; Warita H; Suzuki N; Ikeda K; Mitsuzawa S; Akiyama T; Ono H; Nishiyama A; Izumi R; Kitajima Y; Aoki M
Exp Neurol; 2018 Sep; 307():164-179. PubMed ID: 29932880
[TBL] [Abstract][Full Text] [Related]
16. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.
Rizzo F; Riboldi G; Salani S; Nizzardo M; Simone C; Corti S; Hedlund E
Cell Mol Life Sci; 2014 Mar; 71(6):999-1015. PubMed ID: 24100629
[TBL] [Abstract][Full Text] [Related]
17. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations.
Park HR; Yang EJ
Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573888
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue.
Casula M; Iyer AM; Spliet WG; Anink JJ; Steentjes K; Sta M; Troost D; Aronica E
Neuroscience; 2011 Apr; 179():233-43. PubMed ID: 21303685
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
